Logo Image
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsPeer ExchangeInsightsCase StudiesCase of the QuarterClinical ForumsPractice OwnershipRapid ReadoutShortsVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Daniel G. Fuller, OD, FAAO Dipl., FSLS

Advertisement

Dr. Fuller is the

Articles by Daniel G. Fuller, OD, FAAO Dipl., FSLS

AAOpt 2023: Integrating orthokeratology for myopia management

ByDaniel G. Fuller, OD, FAAO Dipl., FSLS,Emily Kaiser Maharjan, Assistant Managing Editor
October 11th 2023
Daniel G. Fuller, OD, FAAO Dipl., FSLS, shares what he wish he knew before entering the field.

Dr. Fuller: What I wish I knew before entering optometry

ByDaniel G. Fuller, OD, FAAO Dipl., FSLS,Alex Delaney-Gesing, Senior Editor
May 21st 2022

Daniel G. Fuller, OD, FAAO Dipl., FSLS, shares what he wish he knew before entering the field.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Optometry Times - Clinical News & Expert Optometrist Insights

    1

    More than monitoring: Using AMD visits to promote healthy vision aging

    2

    FDA approves Brytly eye drops for ocular redness relief lasting up to 12 hours

    3

    Study: OCTA analysis tools report different macular vessel density values for glaucoma

    4

    Brepocitinib for noninfectious uveitis meets all phase 3 trial end points

    5

    BIM-IOL System holds 37% IOP reduction at 4 years in first-in-human trial

    • Advertise
    • About Us
    • Editorial
    • Contact Us
    • Job Board
    • Terms & Conditions
    • Privacy
    • Do not sell my Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    • Ophthalmology Times
    • Modern Retina
    • Optometry Times
    • Ophthalmology Times Europe
    Collaborative Care Symposium
    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us